Caseware UK (AP4) 2024.0.164 2024.0.164 2025-10-312025-10-312026-05-06falsefalse2024-11-01The provision of pharmacy services3132trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false SC732947 2024-11-01 2025-10-31 SC732947 2023-11-01 2024-10-31 SC732947 2025-10-31 SC732947 2024-10-31 SC732947 c:Director1 2024-11-01 2025-10-31 SC732947 d:PlantMachinery 2025-10-31 SC732947 d:PlantMachinery 2024-10-31 SC732947 d:PlantMachinery d:OwnedOrFreeholdAssets 2024-11-01 2025-10-31 SC732947 d:MotorVehicles 2024-11-01 2025-10-31 SC732947 d:FurnitureFittings 2024-11-01 2025-10-31 SC732947 d:OfficeEquipment 2024-11-01 2025-10-31 SC732947 d:Goodwill 2025-10-31 SC732947 d:Goodwill 2024-10-31 SC732947 d:CurrentFinancialInstruments 2025-10-31 SC732947 d:CurrentFinancialInstruments 2024-10-31 SC732947 d:Non-currentFinancialInstruments 2025-10-31 SC732947 d:Non-currentFinancialInstruments 2024-10-31 SC732947 d:CurrentFinancialInstruments d:WithinOneYear 2025-10-31 SC732947 d:CurrentFinancialInstruments d:WithinOneYear 2024-10-31 SC732947 d:Non-currentFinancialInstruments d:AfterOneYear 2025-10-31 SC732947 d:Non-currentFinancialInstruments d:AfterOneYear 2024-10-31 SC732947 d:ShareCapital 2025-10-31 SC732947 d:ShareCapital 2024-10-31 SC732947 d:RetainedEarningsAccumulatedLosses 2025-10-31 SC732947 d:RetainedEarningsAccumulatedLosses 2024-10-31 SC732947 c:OrdinaryShareClass1 2024-11-01 2025-10-31 SC732947 c:OrdinaryShareClass1 2025-10-31 SC732947 c:OrdinaryShareClass1 2024-10-31 SC732947 c:OrdinaryShareClass2 2024-11-01 2025-10-31 SC732947 c:OrdinaryShareClass2 2025-10-31 SC732947 c:OrdinaryShareClass2 2024-10-31 SC732947 c:FRS102 2024-11-01 2025-10-31 SC732947 c:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 SC732947 c:FullAccounts 2024-11-01 2025-10-31 SC732947 c:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 SC732947 d:Goodwill d:OwnedIntangibleAssets 2024-11-01 2025-10-31 SC732947 e:PoundSterling 2024-11-01 2025-10-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: SC732947










BONNYRIGG HEALTHCARE LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 OCTOBER 2025

 
BONNYRIGG HEALTHCARE LIMITED
REGISTERED NUMBER: SC732947

BALANCE SHEET
AS AT 31 OCTOBER 2025

2025
2024
Note
£
£

Fixed assets
  

Intangible assets
 5 
4,276,495
4,526,354

Tangible assets
 6 
39,863
53,151

  
4,316,358
4,579,505

Current assets
  

Stocks
  
143,305
125,434

Debtors: amounts falling due within one year
 7 
581,486
511,377

Cash at bank and in hand
  
566,158
481,962

  
1,290,949
1,118,773

Creditors: amounts falling due within one year
 8 
(820,101)
(813,984)

Net current assets
  
 
 
470,848
 
 
304,789

Total assets less current liabilities
  
4,787,206
4,884,294

Creditors: amounts falling due after more than one year
 9 
(4,842,288)
(5,043,751)

Provisions for liabilities
  

Deferred tax
  
(3,984)
(6,492)

  
 
 
(3,984)
 
 
(6,492)

Net liabilities
  
(59,066)
(165,949)


Capital and reserves
  

Called up share capital 
  
10
10

Profit and loss account
  
(59,076)
(165,959)

  
(59,066)
(165,949)


Page 1

 
BONNYRIGG HEALTHCARE LIMITED
REGISTERED NUMBER: SC732947
    
BALANCE SHEET (CONTINUED)
AS AT 31 OCTOBER 2025

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 6 May 2026.




Mr R Wooton
Director

Page 2

 
BONNYRIGG HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

1.


General information

Bonnyrigg Healthcare Limited is a private company limited by shares incorporated in Scotland. The registered office is Bonnyrigg Pharmacy, 109-111 High Street, Bonnyrigg, EH19 2ET. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

 
2.2

Going concern

During the period, the company made a profit and had net liabilities as at the balance sheet date.
 
The directors have considered a period of at least twelve months from the date on which these financial statements have been signed and having considered all information available to them, believe it appropriate to prepare the financial statements on a going concern basis.

The directors therefore continue to adopt the going concern basis of accounting in preparing the financial statements. This assessment of going concern takes into account the current inflationary pressures impacting on costs.

 
2.3

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Page 3

 
BONNYRIGG HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

2.Accounting policies (continued)

 
2.4

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed. 

 
2.5

Pensions

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

 
2.6

Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is a maximum of 20 years. 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

At each reporting date the Company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

Page 4

 
BONNYRIGG HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

2.Accounting policies (continued)


2.7
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Motor vehicles
-
25%
Fixtures and fittings
-
25%
Office equipment
-
25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.8

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.9

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

 
2.10

Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Debtors
Debtors with no stated interest rate and payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account.

Creditors
Creditors with no stated interest rate and payable within one year are recorded at transaction price.

 
Page 5

 
BONNYRIGG HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

2.Accounting policies (continued)


2.10
Financial instruments (continued)

All transaction bearing loans and borrowings which are basic financial instruments are initially recognised at the present value of cash payable. After initial recognition they are measured at amortised cost.


  
2.11

Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are 
recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

  
2.12

Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets. 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

  
2.13

Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Page 6

 
BONNYRIGG HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

3.


Judgments and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, 
estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting 
estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.


4.


Employees

The average monthly number of employees, including the directors, during the year was as follows:


        2025
        2024
            No.
            No.







Employees
31
32


5.


Intangible assets




Goodwill

£



Cost


At 1 November 2024
4,997,174



At 31 October 2025

4,997,174



Amortisation


At 1 November 2024
470,820


Charge for the year on owned assets
249,859



At 31 October 2025

720,679



Net book value



At 31 October 2025
4,276,495



At 31 October 2024
4,526,354



Page 7

 
BONNYRIGG HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

6.


Tangible fixed assets


Plant and machinery

£



Cost or valuation


At 1 November 2024
83,586



At 31 October 2025

83,586



Depreciation


At 1 November 2024
30,435


Charge for the year on owned assets
13,288



At 31 October 2025

43,723



Net book value



At 31 October 2025
39,863



At 31 October 2024
53,151


7.


Debtors

2025
2024
£
£


Trade debtors
400,898
391,799

Other debtors
180,588
119,578

581,486
511,377


Page 8

 
BONNYRIGG HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

8.


Creditors: Amounts falling due within one year

2025
2024
£
£

Bank loans
169,572
145,886

Trade creditors
441,362
513,576

Other taxation and social security
160,262
104,666

Other creditors
48,905
49,856

820,101
813,984


The bank loans are secured by way of bond and floating charge over the assets of the company.

Hire Purchase creditors are secured over assets they are related to.


9.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Bank loans
3,107,222
3,305,010

Other creditors
1,735,066
1,738,741

4,842,288
5,043,751


The aggregate amount of liabilities repayable wholly or in part more than five years after the balance sheet date is:

2025
2024
£
£


Repayable by instalments
558,417
620,353

558,417
620,353

The bank loans are secured by way of bond and floating charge over the assets of the company.

Hire Purchase creditors are secured over assets they are related to.

Page 9

 
BONNYRIGG HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025

10.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



670 (2024 - 670) Ordinary shares shares of £0.01 each
7
7
330 (2024 - 330) Ordinary "A" shares shares of £0.01 each
3
3

10

10


 
Page 10